Detalhe da pesquisa
1.
Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition.
Cancer Res
; 76(2): 390-402, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577700